Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-2.019999 (-100.00%)
At close: Nov 21, 2025
ZHYBF Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Net Income | 0.3 | -2.15 | -1.13 | -0.03 | -0.09 |
Depreciation & Amortization | 0.12 | 0.16 | 0.17 | 0.18 | 0.02 |
Loss (Gain) From Sale of Assets | 0 | 0.09 | - | - | 0 |
Stock-Based Compensation | - | 0.05 | 0.32 | - | - |
Other Operating Activities | -0.03 | 0.64 | 0.47 | - | - |
Change in Accounts Receivable | -0.44 | -0.17 | 0.07 | 0.07 | 0.01 |
Change in Inventory | 0.1 | -0.08 | 0.01 | 0.16 | 0.01 |
Change in Accounts Payable | - | - | - | -0 | - |
Change in Other Net Operating Assets | -0.81 | 0.49 | -0.03 | -0.07 | -0.1 |
Operating Cash Flow | -0.75 | -1.03 | -0.25 | 0.31 | -0.15 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Capital Expenditures | - | -0.02 | -0 | -0.01 | -0.01 |
Cash Acquisitions | - | - | - | 0 | -0.45 |
Divestitures | - | 0.14 | - | - | - |
Investment in Securities | - | - | - | - | 0.33 |
Investing Cash Flow | - | 0.12 | -0 | -0 | -0.13 |
Financing Activities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Short-Term Debt Issued | - | 0.25 | - | - | 0.11 |
Long-Term Debt Issued | 1.57 | 1.02 | 0.57 | 0.66 | 0.47 |
Total Debt Issued | 1.57 | 1.27 | 0.57 | 0.66 | 0.58 |
Short-Term Debt Repaid | - | -0.08 | -0.14 | -0.3 | -0.18 |
Long-Term Debt Repaid | -0.97 | -0.43 | -0.4 | -0.46 | -0.2 |
Total Debt Repaid | -0.97 | -0.51 | -0.54 | -0.76 | -0.38 |
Net Debt Issued (Repaid) | 0.6 | 0.76 | 0.03 | -0.1 | 0.21 |
Issuance of Common Stock | 0.11 | 0.53 | 0.23 | 0.05 | 0.15 |
Repurchase of Common Stock | - | - | - | -0.05 | - |
Financing Cash Flow | 0.72 | 1.3 | 0.26 | -0.1 | 0.35 |
Net Cash Flow
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Foreign Exchange Rate Adjustments | -0.1 | -0.21 | -0.1 | -0.08 | -0.02 |
Net Cash Flow | -0.13 | 0.18 | -0.09 | 0.13 | 0.06 |
Free Cash Flow
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Free Cash Flow | -0.75 | -1.05 | -0.26 | 0.3 | -0.15 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -32.74% | -63.02% | -10.96% | 18.56% | -12.64% |
Free Cash Flow Per Share | -0.04 | -0.06 | -0.01 | 0.02 | -0.01 |
Levered Free Cash Flow | -0.89 | 0.9 | 0.25 | -0.41 | -0.14 |
Unlevered Free Cash Flow | -0.84 | 0.93 | 0.27 | -0.4 | -0.13 |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash Interest Paid | 0.08 | 0.05 | 0.04 | 0.02 | 0.01 |
Cash Income Tax Paid | - | 0 | 0.01 | 0 | 0.02 |
Change in Working Capital | -1.14 | 0.24 | 0.05 | 0.15 | -0.08 |